Home/ Stocks/ PMN

ProMIS Neurosciences Inc. Common Shares (ON)

PMN XNAS

$17.43 -0.34 (-1.91%) ▼ 15-min delayed

Open

$17.31

High

$18.71

Low

$17.31

Volume

16.5K

Market Cap

$38.25M

About ProMIS Neurosciences Inc. Common Shares (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 8 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-11,580,126	$-0.24
Q1 2025	$0	$-7,347,903	$-0.21
FY 2024	$0	$2.78M	$0.11
Q3 2024	$0	$9.28M	$0.31

Earnings & Analyst Ratings

Next Earnings: Mon, May 11, 2026

Calendar →

Related Market News

No specific coverage for PMN yet. Check out our latest market news or earnings calendar.

Get PMN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on ProMIS Neurosciences Inc. Common Shares (ON).

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.